Project Grant R01DK142743
- Federal Grant Award Summary Beth Israel Deaconess Medical Center, Inc. (BIDMC) received a $765,701 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, dated September 9, 2025, with a completion date of May 31, 2030, supports fundamental neuroscience research aimed at mapping mechanosensory circuits that transmit bladder fullness signals to the...
- Federal Grant Award Summary Beth Israel Deaconess Medical Center, Inc. received a $191,234 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective August 1, 2025 through July 31, 2030. The research initiative addresses gastric dopaminergic signaling and mucosal injury in Parkinson's disease, investigating mechanisms by which L-amino acid...
- Federal Project Grant Award Summary Brandeis University received $784,966 in funding from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award, which commenced September 15, 2025, and concludes June 30, 2030, supports fundamental research investigating the sensory functions of pharyngeal enteric neurons in Caenorhabditis elegans. The research focuses on elucidating...
- Federal Project Grant Award Summary Harvard Medical School received an $830,414 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective August 13, 2025, with a completion date of June 30, 2030. The award supports research focused on identifying and characterizing microbiome-derived sulfated metabolites and their biological effects on human...
- Federal Grant Award Summary The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Boston Children's Hospital a $168,900 project grant effective July 15, 2025, through May 31, 2029, under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). This research initiative investigates the mechanistic pathways by which Blautia species—commensal bacteria—activate enteroendocrine cells to produce satiety hormones and support gastrointestinal...
- Federal Project Grant Award Summary Beth Israel Deaconess Medical Center, Inc. received a Project Grant award of $854,803 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective June 13, 2025, with an anticipated completion date of May 31, 2030. The award funds the development of a comprehensive, curated data repository for indirect calorimetry experiments in mice...
- Federal Grant Award Summary Dana-Farber Cancer Institute, Inc. received a $740,581 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded April 1, 2026, with completion targeted for January 31, 2031. The grant funds basic biomedical research investigating the niche regulation of gastric epithelial cell differentiation, specifically examining how...
- Federal Grant Award Summary Beth Israel Deaconess Medical Center, Inc. received a $737,034 Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct basic biomedical research on coenzyme A (CoA) biosynthesis regulation and its relationship to metabolic dysfunction-associated fatty liver disease and chronic kidney disease. The award, effective September...
- Federal Project Grant Award Summary Beth Israel Deaconess Medical Center, Inc. received a $659,358 project grant awarded September 4, 2025, by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The award supports basic biomedical research focused on understanding APOL1 (apolipoprotein L1) nephropathy and its genetic mechanisms through June 30, 2030. The research utilizes...
- Federal Grant Award Summary Boston Children's Hospital received a $3.1 million Project Grant from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded September 3, 2025, with a completion date of September 2, 2029. This four-year research project investigates the role of lipogenic (fat-generating) pathways in intestinal remodeling following Roux-en-Y gastric bypass (RYGB)...
Beth Israel Deaconess Medical Center, Inc. (BIDMC) received a $834,911 Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), effective April 1, 2026, with completion targeted for January 31, 2031. The award supports fundamental neuroscience research aimed at creating the first comprehensive mammalian roadmap of selective brain-to-gut communication circuits. Specifically, the research leverages transcriptional diversity and genetic approaches in mouse models to map connections between dorsal motor nucleus of the vagus (DMV) neuron subtypes and enteric nervous system (ENS) neuron subtypes, advancing understanding of how the central nervous system controls gastrointestinal physiology from the distal esophagus to proximal colon. The deliverables include the development of detailed neuroanatomical and functional characterization of DMV-to-ENS motor circuits that mediate parasympathetic control of gastrointestinal responses. Building on preliminary single nuclei RNA sequencing (snRNA-seq) atlas data, the project applies neuron subtype-specific genetic and molecular tools to uncover and selectively manipulate previously uncharacterized circuit connections. These research products are designed to establish the feasibility and provide a foundational roadmap for understanding the highly specific neural circuits controlling gastrointestinal function, with potential implications for future therapeutic interventions in digestive diseases.Federal Project Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $834.9k | 3/18/26 |